Home » Biotechnology » Cell Signaling Market

Cell Signaling Market By Product Type (Antibodies, Reagents, Cellular Assay Kits), By Pathway (PI3K/ AKT Signaling Pathway, AMPK Signaling Pathway, ErbB/Her Signaling Pathway, Hedgehog Signaling Pathway, Hippo Signaling Interactive Pathway, JAK/STAT Signaling Pathway, Notch Signaling Pathway), By Application (Drug Discovery, Adme Studies, Predictive Toxicology Studies, Cancer Research, Stem Cells Research) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2025

Price: $4999

Published: | Report ID: 3698 | Report Format : PDF

Market Insights

Cell signaling is a complex process of communication that governs the basic activities of cells and coordinates cell actions. Factors such as the growing applicability of cell signaling in biotechnology and medical industries, advancements in cell-based research technology, the growing number of biopharmaceutical industries, and the wide availability of advanced cell signaling are driving the growth of the cell signaling market globally.

The report titled “Cell Signaling Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall cell signaling market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on the pathway, product type, application, and different geographical regions.

Geographically, the global cell signaling market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global cell signaling market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global cell signaling market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global cell signaling market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global cell signaling market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on product type, the global cell signaling market is segmented as follows:

  • Antibodies
  • Reagents
  • Cellular Assay Kits
  • Others

Cell signaling is a complex process of communication that governs the basic activities of cells and coordinates cell actions. Cell signaling is necessary for tissue repair, immunity, and normal tissue homeostasis. Furthermore, disruption in cell signaling leads to the development of diseases such as cancer, autoimmunity, and diabetes. Cell signaling is a major field in modern medical practice and diagnosis. Factors such as the growing applicability of cell signaling in R&D, the increase in the incidence of chronic disease, advancements in cell-based research technology, growing biopharmaceutical industries, and the wide availability of different cell signaling products are driving the growth of the cell signaling market globally. For the purpose of the study, the cell signaling market is segmented on the basis of product types, such as antibodies, reagents, cellular assay kits, and other cellular signaling products. It is studied that, in the base year 2016, antibodies held the largest market share due to their wide applicability in molecular biology, increased use in research and the drug discovery process, and their fundamental role in disease detection, structural analysis, sequencing, and mapping, which are driving the growth of the antibodies market in cell signaling.

Based on pathways, the global cell signaling market is segmented as follows:

  • PI3K/AKT Signaling Pathway
  • AMPK signaling pathway
  • ErbB/HER Signaling Pathway
  • Pathway of Hedgehog Signaling
  • Interactive Hippo Signaling Pathway
  • JAK/STAT Signaling Pathway
  • Pathway of Notch Signaling
  • Other cell signaling pathways

Cell signaling governs the basic activities of cells and coordinates cell actions through a complex coordination of responses to the cellular microenvironment. The errors in cell signaling lead to the development of diseases such as cancer, autoimmunity, and diabetes. Cell signaling is a major field in modern medical practice and diagnosis. There are numerous cell signaling pathways that exist; for the purpose of this study, the market is segmented on the basis of pathways such as the AKT signaling pathway, the AMPK signaling pathway, the ErbB/HER signaling pathway, the hedgehog signaling pathway, the hippo signaling interactive pathway, the JAK/STAT signaling pathway, the notch signaling pathway, and other cell signaling pathways. It is observed that, in the base year 2016, the PI3K/AKT signaling pathway was a major revenue-generating segment. As it plays an important role in the regulation of various cellular functions such as metabolism, growth, proliferation, survival, transcription, and protein synthesis, AKT has been implicated in diseases including cancer, diabetes, and neuro-degeneration and is thus widely accepted in basic research and drug development.

Based on application, the global cell signaling market is segmented as follows:

  • Drug Discovery
  • ADME Studies
  • Predictive toxicology studies
  • Cancer Research
  • Stem Cell Study
  • Other Applications

Cell signaling is a complex process through which living cells interact with the cellular environment and neighboring cells. Error or disruption in cell signaling leads to the development of diseases such as cancer, autoimmunity, and diabetes; thus, by understanding cell signaling, diseases may be treated more effectively. Cell signaling has wide applications in the medical and research industries; however, for the purpose of this study, the cell signaling market is segmented on the basis of applications such as drug discovery, ADME studies, predictive toxicology studies, cancer research, stem cell research, and other applications. It is observed that, in the base year 2016, cell signaling applications in cancer research were a major revenue-generating segment and are anticipated to show similar growth during the forecast period. Factors such as the increase in the use of cell signaling techniques in cancer research and drug discovery are prime factors that are driving the growth of cell signaling applications in the cancer research market globally.

For the purpose of this study, the cell signaling market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

It is observed that, in the base year 2016, North America was the largest revenue contributor in the global cell signaling market and occupied a significant portion of the global market; the United States was observed as the largest revenue-generating market in North America. Technological advancement, increased investment in R&D activities, the presence of a large number of biotechnology and biopharmaceutical industries, the presence of a large number of research institutes, and growing life science and biopharmaceutical industries are the primary drivers of cell signaling market growth in North America. However, Asia Pacific will show the highest growth during the forecast period because of increasing government investments in the life sciences sector. Moreover, huge investments in basic research and drug discovery and rapidly expanding biopharmaceutical industries in this region would assist the market’s growth during the forecast period. Emerging Asian countries such as China and India are expected to drive market growth [J1] due to increasing R&D activities and growing partnerships of key players with local manufacturers, which would drive cell signaling market growth.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Cell Signaling Market Snapshot
2.2 Global Cell Signaling Market, by Product Type
2.3 Global Cell Signaling Market, by Pathway, 2016 (US$ Bn)
2.4 Global Cell Signaling Market, by Application, 2016 (US$ Bn)
2.5 Global Cell Signaling Market Share, by Geography, 2016 (Value %)

Chapter 3 Cell Signaling Market Analysis
3.1 Global Cell Signaling Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Cell Signaling Market

Chapter 4 Global Cell Signaling Market, by Product Type
4.1 Overview
4.2 Attractive Investment Proposition: Global Cell Signaling Market, by Product Type
4.3 Top 3 Countries
4.4 Antibodies
4.5 Reagents
4.6 Cellular Assay Kits
4.7 Other

Chapter 5 Global Cell Signaling Market, by Pathway
5.1 Overview
5.2 Attractive Investment Proposition: Global Cell Signaling Market, by Pathway
5.3 Top 3 Countries
5.4 PI3K/ AKT Signaling Pathway
5.5 AMPK Signaling Pathway
5.6 ErbB/HER Signaling Pathway
5.7 Hedgehog Signaling Pathway
5.8 Hippo Signaling Interactive Pathway
5.9 JAK/STAT Signaling Pathway
5.10 Notch Signaling Pathway
5.11 Other Cell Signaling Pathways

Chapter 6 Global Cell Signaling Market, by Application
6.1 Overview
6.2 Attractive Investment Proposition: Global Cell Signaling Market, by Application
6.3 Top 3 Countries
6.4 Drug Discovery
6.5 ADME Studies
6.6 Predictive Toxicology Studies
6.7 Cancer Research
6.8 Stem Cells Research
6.9 Other Applications

Chapter 7 Global Cell Signaling Market, By Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.2.1 North America Cell SignalingMarket, by Product Type, 2015- 2025 (US$)
7.2.2 North America Cell Signaling Market, by Pathway, 2015- 2025 (US$)
7.2.3 North America Cell SignalingMarket, by Application, 2015- 2025 (US$)
7.2.4 North America Cell SignalingMarket, by Country, 2015- 2025 (US$)
7.3 Europe (U.K., Germany & Rest of Europe)
7.3.1 Europe Cell SignalingMarket, by Product Type, 2015- 2025 (US$)
7.3.2 Europe Cell Signaling Market, by Pathway, 2015- 2025 (US$)
7.3.3 Europe Cell SignalingMarket, by Application, 2015- 2025 (US$)
7.3.4 Europe Cell Signaling Market, by Country, 2015- 2025 (US$)
7.4 Asia Pacific (China, Japan and Rest of APAC)
7.4.1 Asia Pacific Cell Signaling Market, by Product Type, 2015- 2025 (US$)
7.4.2 Asia Pacific Cell Signaling Market, by Pathway, 2015- 2025 (US$)
7.4.3 Asia Pacific Cell SignalingMarket, by Application, 2015- 2025 (US$)
7.4.1 Asia Pacific Cell Signaling Market, by Country, 2015- 2025 (US$)
7.5 Latin America (Brazil, Mexico and Rest of LATAM)
7.5.1 Latin America Cell Signaling Market, by Product Type, 2015- 2025 (US$)
7.5.2 Latin America Cell Signaling Market, by Pathway, 2015- 2025 (US$)
7.5.3 Latin America Cell Signaling Market, by Application, 2015- 2025 (US$)
7.5.4 Latin America Cell Signaling Market, by Country, 2015- 2025 (US$)
7.6 Middle East and Africa (GCC and Rest of MEA)
7.6.1 Middle East and Africa Cell Signaling Market, by Product Type, 2015- 2025 (US$)
7.6.2 Middle East and Africa Cell Signaling Market, by Pathway, 2015- 2025 (US$)
7.6.3 Middle East and Africa Cell Signaling Market, by Application, 2015- 2025 (US$)
7.6.4 Middle East and Africa Cell Signaling Market, by Country, 2015- 2025 (US$)

Chapter 8 Company Profiles
8.1 Abcam plc.
8.2 BD Biosciences
8.3 Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
8.4 Bio-Rad Laboratories, Inc.
8.5 BioVision, Inc.
8.6 BPS Bioscience, Inc.
8.7 Cell Biolabs, Inc.
8.8 Cell Signaling Technology, Inc.
8.9 Cisbio Bioassays
8.10 Full Moon BioSystems, Inc.
8.11 Merck KGaA
8.12 Miltenyi Biotec
8.13 PerkinElmer Inc.
8.14 Promega Corporation
8.15 Qiagen N.V.
8.16 Rockland Immunochemicals
8.17 Sino Biological, Inc.
8.18 Thermo Fisher Scientific, Inc.

List of Figures

FIG. 1 Cell Signaling Market: Research Methodology
FIG. 2 Global Cell Signaling Market, by Product Type, 2016 (US$ Bn)
FIG. 3 Global Cell Signaling Market, by Pathway, 2016 (US$ Bn)
FIG. 4 Global Cell Signaling Market, by Application, 2016 (US$ Bn)
FIG. 5 Global Cell Signaling Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition: Global Cell Signaling Market, by Geography, 2016
FIG. 7 Attractive Investment Proposition: Global Cell Signaling Market, by Product type, 2016
FIG. 8 Global Antibodies in Cell Signaling Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Reagents in Cell Signaling Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Cellular Assay Kits in Cell Signaling Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Other Products in Cell Signaling Market, 2015 – 2025 (US$ Bn)
FIG. 12 Attractive Investment Proposition: Global Cell Signaling Market, by Pathway, 2016
FIG. 13 Global Cell Signaling Market for PI3K/ AKT Signaling Pathway, 2015 – 2025 (US$ Bn)
FIG. 14 Global Cell Signaling Market for AMPK Signaling Pathway, 2015 – 2025 (US$ Bn)
FIG. 15 Global Cell Signaling Market for ErbB/HER Signaling Pathway, 2015 – 2025 (US$ Bn)
FIG. 16 Global Cell Signaling Market for Hedgehog Signaling Pathway, 2015 – 2025 (US$ Bn)
FIG. 17 Global Cell Signaling Market for Hippo Signaling Interactive Pathway, 2015 – 2025 (US$ Bn)
FIG. 18 Global Cell Signaling Market for JAK/STAT Signaling Pathway, 2015 – 2025 (US$ Bn)
FIG. 19 Global Cell Signaling Market for Notch Signaling Pathway, 2015 – 2025 (US$ Bn)
FIG. 20 Global Cell Signaling Market for Other Cell Signaling Pathways, 2015 – 2025 (US$ Bn)
FIG. 21 Attractive Investment Proposition: Global Cell Signaling Market, by Application, 2016
FIG. 22 Global Drug Discovery Market, 2015 – 2025 (US$ Bn)
FIG. 23 Global ADME Studies Market, 2015 – 2025 (US$ Bn)
FIG. 24 Global Predictive Toxicology Studies Market, 2015 – 2025 (US$ Bn)
FIG. 25 Global Cancer Research Market, 2015 – 2025 (US$ Bn)
FIG. 26 Global Stem Cells Research Market, 2015 – 2025 (US$ Bn)
FIG. 27 Global Other Applications Market, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Cell Signaling Market
TABLE 2 Global Cell Signaling Market, by Product Type, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Cell Signaling Market, by Product Type 2015 – 2025 (US$ Bn)
TABLE 4 Global Cell Signaling Market, by Pathway, 2015 – 2025 (US$ Bn)
TABLE 5 Top 3 Countries in Global Cell Signaling Market, 2015 – 2025 (US$ Bn)
TABLE 6 Global Cell Signaling Market, by Application, 2015 – 2025 (US$ Bn)
TABLE 7 Top 3 Countries in Global Cell Signaling Market, by Application 2015 – 2025 (US$ Bn)
TABLE 8 Global Cell Signaling Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 9 North America Cell Signaling Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 10 North America Influenza Diagnostics Market, by Pathway, 2015-2025 (US$ Bn)
TABLE 11 North America Cell Signaling Market, by Application, 2015-2025 (US$ Bn)
TABLE 12 North America Cell Signaling Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Europe Cell Signaling Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 14 Europe Cell Signaling Market, by Pathway, 2015-2025 (US$ Bn)
TABLE 15 Europe Cell Signaling Market, by Application, 2015-2025 (US$ Bn)
TABLE 16 Europe Cell Signaling Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 17 Asia Pacific Cell Signaling Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 18 Asia Pacific Cell Signaling Market, by Pathway, 2015-2025 (US$ Bn)
TABLE 19 Asia Pacific Cell Signaling Market, by Application, 2015-2025 (US$ Bn)
TABLE 20 Asia Pacific Cell Signaling Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 21 Latin America Cell Signaling Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 22 Latin America Cell Signaling Market, by Pathway, 2015-2025 (US$ Bn)
TABLE 23 Latin America Cell Signaling Market, by Application, 2015-2025 (US$ Bn)
TABLE 24 Latin America Cell Signaling Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 25 Middle East and Africa Cell Signaling Market, by Product Type, 2015-2025 (US$ Bn)
TABLE 26 Middle East and Africa Cell Signaling Market, by Pathway, 2015-2025 (US$ Bn)
TABLE 27 Middle East and Africa Cell Signaling Market, by Application, 2015-2025 (US$ Bn)
TABLE 28 Middle East and Africa Cell Signaling Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 29 Abcam plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 30 BD Biosciences: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 31 Beckman Coulter, Inc. (a subsidiary of Danaher Corporation): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 32 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 33 BioVision, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 34 BPS Bioscience, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 35 Cell Biolabs, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 36 Cell Signaling Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 37 Cisbio Bioassays: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 38 Full Moon BioSystems, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 39 Merck KGaA: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 40 Miltenyi Biotec: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 41 PerkinElmer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 42 Promega Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 43 Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 44 Rockland Immunochemicals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 45 Sino Biological, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 46 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

Frequently Asked Questions

What is the size of Cell Signaling Market?

The market for Cell Signaling is expected to reach US$ 4.35 Bn in 2025.

What is the Cell Signaling Market CAGR?

The Cell Signaling market is expected to see significant CAGR growth over the coming years,at 6.4%.

What is the Forecast period considered for Cell Signaling Market?

The report is forecasted from 2015-2025.

What is the base year considered for Cell Signaling Market?

The base year of this report is 2014.

Who are the major players in this Market?

Abcam plc.,BD Biosciences,Beckman Coulter, Inc.(a subsidiary of Danaher Corporation),Bio-Rad Laborator,BioVision, Inc. are some of the major players in the global market.

Bioengineered Skin And Skin Substitutes Market

Published:
Report ID: 3472

DNA and RNA Sample Preparation Market

Published:
Report ID: 34911

Laboratory Filtration Market

Published:
Report ID: 7940

Adult Hemoglobinopathy Testing Market

Published:
Report ID: 34717

Nanobiotechnology Market

Published:
Report ID: 14350

Canine Stem Cell Therapy Market

Published:
Report ID: 34386

Humanized Mice Model Market

Published:
Report ID: 34329

Mobile Water Treatment Systems Market

Published:
Report ID: 19203

Environmental Testing Equipment Market

Published:
Report ID: 33589

Biological Safety Cabinets Market

Published:
Report ID: 1536

Glycosaminoglycans (GAGs) Market

Published:
Report ID: 33489

Nontuberculous Mycobacterial (NTM) Infection Market

Published:
Report ID: 33051

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN